论文部分内容阅读
据1997年在芬兰举行的第十六次国际糖尿病联合会介绍的最新临床资料，新型抗糖尿病药曲格列酮（troglitazone）能降低Ⅱ型糖尿病患者尿中白蛋白含量，并可预防患者并发心血管疾病和肾损害，这两种并发症是糖尿病患者过早死亡的首要原因。尿中白蛋白含量升高是Ⅱ型糖尿病人心血?
According to the latest clinical data presented by the 16th International Diabetes Federation in Finland in 1997, the new antidiabetic troglitazone reduces urinary albumin levels in patients with type 2 diabetes and can prevent patients with concomitant heart disease Vascular disease and kidney damage, both of which are the leading causes of premature death in diabetic patients. Urinary albumin content is type Ⅱ diabetes in people with blood pressure?